The global anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4% from 2018 to 2023. In 2017, Thermo Fisher Scientific (US), Leica Biosystems (Germany), Ventana Medical Systems (US), Agilent Technologies (US), and General Data Healthcare (US) were the major players operating in the anatomic pathology track and trace solutions market. These players together accounted for a market share of 50–55% in 2017.
Thermo Fisher Scientific accounted for the largest share of the global anatomic pathology track and trace solutions market in 2017. The company offers track and trace solutions for anatomic pathology laboratories through its Specialty Diagnostics segment. Thermo Fisher operates in over 50 countries across North America, the Asia Pacific, Europe, and Latin America. Over the years, the company has maintained its leading position in the market through continuous innovation and product development. For instance, in May 2015, the company launched two new cassette and slide labeling systems, namely, the SlideMate slide printer and PrintMate AS cassette printer for anatomic pathology laboratories. Thermo Fisher’s wide product offerings along with a strong geographical network help it to maintain its leading position in the market.
To know about the assumptions considered for the study download the pdf brochure
Leica Biosystems held the second position in the global anatomic pathology track and trace solutions market in 2017. Leica Biosystems is a wholly owned subsidiary of Danaher Corporation (US). Over the years, the company has maintained its leading position in the market through continuous innovation and the launch of advanced products. For instance, in June 2017, Leica expanded its portfolio of slide identification products by adding the HistoCore PERMA S slide printing solution. The company is also focusing on inorganic growth strategies to increase its presence in the market. In the last three years, Leica Biosystems has entered into 6 strategic partnerships, collaborations, and agreements.
Ventana Medical Systems held the third position in the global anatomic pathology track and trace solutions market in 2017. Ventana Medical Systems, Inc. manufactures and distributes pathology lab systems (that automate tissue processing), and is a wholly owned subsidiary of Roche Diagnostics. The company’s intuitive, integrated staining workflow management platforms and digital pathology solutions optimize laboratory efficiencies. The Ventana product portfolio is one of the top-selling brands of Roche Diagnostics. In 2017, Ventana, including VANTAGE workflow solutions, accounted for 11% of Roche’s total revenue. The company’s VANTAGE workflow solutions provide specimen tracking solutions for anatomic pathology laboratories. Ventana Medical Systems has installed more than 6,000 systems in more than 3,000 laboratories across 35 countries, globally. Also, the company has a global network of authorized dealers and has customers in more than 100 countries.
Some of the other players competing in the anatomic pathology track and trace solutions market are Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) - Global Forecast to 2023
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE